ILA 2.47% 8.3¢ island pharmaceuticals limited

Ann: ISLA-101 Phase 2a/b clinical trial progresses, page-24

  1. 455 Posts.
    lightbulb Created with Sketch. 73
    Find me a biotech with an upcoming P2 trial starting in October and finishing before end of CY. Unheard of in this space. The price still this low is a blessing in disguise if you ask me. Of course there is every chance that trial fails and then we are all up sh!t creek....but that's the gamble we take in this game.
 
watchlist Created with Sketch. Add ILA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.